YALLIG‘LANISHLI ICHAK KASALLIKLARIDA EPITELIAL BARRIERNING MORFOLOGIK VA ULTRASTRUKTURAVIY BUZILISHI

Authors

  • Berdikulova Mushtariybegim Shavkat qizi Toshkent davlat tibbiyot universiteti,Tibbiy pedagogika va davolash fakulteti 302-DI guruh talabasi, Tashkent-2026
  • Alimova Farangiz Shuxrat qizi Toshkent davlat tibbiyot universiteti,Tibbiy pedagogika va davolash fakulteti 302-DI guruh talabasi, Tashkent-2026

Keywords:

yallig‘lanishli ichak kasalliklari, ichak epiteliyi, epitelial barrier, tight junction, desmosoma, adherens junction, Kron kasalligi, yarali kolit, ultrastruktura, enterotsit, ichak o‘tkazuvchanligi.

Abstract

Yallig‘lanishli ichak kasalliklari, xususan, Kron kasalligi va yarali kolit, ichak shilliq qavatining surunkali yallig‘lanishi bilan kechadigan kasalliklar bo‘lib, ularning rivojlanishida epitelial barrier funksiyasining buzilishi muhim o‘rin tutadi. Ichak epiteliy qavati nafaqat oziq moddalarining so‘rilishini ta’minlaydi, balki ichak bo‘shlig‘idagi mikroorganizmlar, toksinlar va antigenlarning ichki muhitga o‘tishini cheklovchi himoya tizimi sifatida ham faoliyat yuritadi. Ushbu maqolada yallig‘lanishli ichak kasalliklarida ichak epiteliyining morfologik va ultrastrukturaviy o‘zgarishlari, hujayralararo birikmalarning buzilishi, tight junction oqsillarining o‘zgarishi, mikroburmalar va shilliq qavatning yaxlitligi buzilishining patogenetik ahamiyati tahlil qilindi. Tahlillar shuni ko‘rsatadiki, epitelial barrierning buzilishi ichak o‘tkazuvchanligining ortishiga, mikrobiota komponentlarining shilliq qavat orqali kirib borishiga va yallig‘lanish jarayonining kuchayishiga olib keladi. Shu sababli epitelial barrierning morfologik va molekulyar holatini o‘rganish yallig‘lanishli ichak kasalliklarining patogenezini tushunish hamda yangi diagnostik va terapevtik yondashuvlarni ishlab chiqishda muhim ahamiyatga ega.

References

1.Turner JR. Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology. 2009;9:799–809.

2.Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nature Reviews Immunology. 2014;14:141–153.

3.Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Experimental & Molecular Medicine. 2018;50:1–9.

4.Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nature Reviews Molecular Cell Biology. 2016;17:564–580.

5.Chang JT. Pathophysiology of inflammatory bowel diseases. New England Journal of Medicine. 2020;383:2652–2664.

6.Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578:527–539.

7.Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmunity Reviews. 2014;13:3–10.

8.Abraham C, Cho JH. Inflammatory bowel disease. New England Journal of Medicine. 2009;361:2066–2078.

9.Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Review of Gastroenterology & Hepatology. 2017;11:821–834.

10.Turner JR. Molecular basis of epithelial barrier regulation. American Journal of Pathology. 2006;169:1901–1909.

11.Luissint AC, Parkos CA, Nusrat A. Inflammation and the intestinal barrier: leukocyte-epithelial cell interactions, cell junction remodeling, and mucosal repair. Gastroenterology. 2016;151:616–632.

12.Johansson MEV, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nature Reviews Immunology. 2016;16:639–649.

13.Torres J, Mehandru S, Colombel JF, Peyrin-BirouletA L. Crohn’s disease. The Lancet. 2017;389:1741–1755.

14.Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. The Lancet. 2017;389:1756–1770.

15.Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cellular and Molecular Life Sciences. 2013;70:631–659.

16.Martini E, Krug SM, Siegmund B, Neurath MF, Becker C. Mend your fences—the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease. Cellular and Molecular Gastroenterology and Hepatology. 2017;4:33–46.

17.Nalle SC, Turner JR. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and COVID-19. Cellular and Molecular Gastroenterology and Hepatology. 2021;11:1–13.

18.Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and increased epithelial permeability in active Crohn’s disease. Gut. 2007;56:61–72.

19.Schmitz H, Barmeyer C, Gitter AH, et al. Epithelial barrier and transport function of the intestinal mucosa in inflammatory bowel disease. Gastroenterology.

20.Neurath MF. Cytokines in inflammatory bowel disease. Nature Reviews Immunology. 2014;14:329–342.

Downloads

Published

2026-09-22

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.